Home / Pharmacology / Enzymes / Kinases / Cyclin-Dependent Kinases (CDKs) / Non-selective CDKs / Non-selective CDK Inhibitors / AZD 5438

AZD 5438

Cat. No. 3968 4 Citations Submit a Review Datasheet / COA / SDS
Pricing Availability   Qty
Description: Cdk inhibitor; potently inhibits cdk1, 2, 5 and 9
Chemical Name: 4-[2-Methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]-2-pyrimidinamine
Purity: ≥99% (HPLC)
Datasheet
Citations (4)
Reviews
Biological Activity Technical Data Solubility Calculators Datasheets References

Biological Activity for AZD 5438

AZD 5438 is a potent inhibitor of cyclin dependent kinases (cdks; reported IC50 values are 6 - 45, 14, 16 and 20 nM for cdk2, cdk5, cdk1 and cdk9 respectively). Also inhibits cdk4 and cdk7 in the sub micromolar range. Exhibits antiproliferative activity in human tumor cell lines. Blocks cell cycling at G2-M, S and G1 phases; reduces the proportion of actively cycling cells in vivo.

Licensing Information

Sold with the permission of AstraZeneca UK Ltd.

Compound Libraries for AZD 5438

AZD 5438 is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Kinase Inhibitor Library. Find out more about compound libraries available from Tocris.

Technical Data for AZD 5438

M. Wt 371.46
Formula C18H21N5O2S
Storage Desiccate at RT
Purity ≥99% (HPLC)
CAS Number 602306-29-6
PubChem ID 16747683
InChI Key WJRRGYBTGDJBFX-UHFFFAOYSA-N
Smiles CS(C(C=C3)=CC=C3NC1=NC(C2=CN=C(C)N2C(C)C)=CC=N1)(=O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for AZD 5438

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 37.15 100

Preparing Stock Solutions for AZD 5438

The following data is based on the product molecular weight 371.46. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 2.69 mL 13.46 mL 26.92 mL
5 mM 0.54 mL 2.69 mL 5.38 mL
10 mM 0.27 mL 1.35 mL 2.69 mL
50 mM 0.05 mL 0.27 mL 0.54 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

References for AZD 5438

References are publications that support the biological activity of the product.

Byth et al (2009) AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2 and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. Mol.Cancer Ther. 8 1856 PMID: 19509270

Jorda et al (2018) How selective are pharmacological inhibitors of cell-cycle-regulating cyclin-dependent kinases? J.Med.Chem. 61 9105 PMID: 30234987

If you know of a relevant reference for AZD 5438, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Non-selective CDK Inhibitors

Keywords: AZD 5438, AZD 5438 supplier, AZD5438, Cdk, inhibitor, cyclin-dependent, kinase, inhibitors, inhibits, cdk1, cdk2, cdk9, Cell, Cycle, Inhibitors, Cyclin-dependent, Kinase, Non-selective, CDKs, 3968, Tocris Bioscience

4 Citations for AZD 5438

Citations are publications that use Tocris products. Selected citations for AZD 5438 include:

Natrajan et al (2012) Functional characterization of the 19q12 amplicon in grade III breast cancers. Breast Cancer Res 14 R53 PMID: 22433433

Cheng et al (2022) Translational and post-translational control of human naïve versus primed pluripotency. iScience 25 103645 PMID: 35005567

Helen et al (2023) AZD5438 a GSK-3a/b and CDK inhibitor is antiapoptotic modulates mitochondrial activity and protects human neurons from mitochondrial toxins. Sci Rep 13 8334 PMID: 37221196

Goonesekere et al (2014) A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers. PLoS One 9 e93046 PMID: 24740004

Do you know of a great paper that uses AZD 5438 from Tocris? Please let us know.

Reviews for AZD 5438

There are currently no reviews for this product. Be the first to review AZD 5438 and earn rewards!

Have you used AZD 5438?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review